2022-04-04

NJBIZ Conversations: Chris Beddard

Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD

Chris Beddard is the Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD.

In this interview with NJBIZ, she speaks about the BD Onclarity™ HPV Assay, an HPV test with extended genotyping that holds the promise of improved outcomes. As long as women use it.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD
Cervical Cancer | News & Updates
NJBIZ Conversations: Chris Beddard
ReachMD: A review of risk in cervical cancer: An analysis of the ASCCP guidelines & NCI risk matrix
Cervical Cancer | Webinars & Videos
ReachMD: A review of risk in cervical cancer: An analysis of the ASCCP guidelines & NCI risk matrix
New study shows substandard approaches to diagnosis and treatment for vaginal discharge syndromes
Vaginitis | News & Updates
Press release: New study shows substandard approaches to diagnosis and treatment for vaginal discharge syndromes